Are the Norwegian health research investments in line with the disease burden?

Jonas Minet Kinge; Ingrid Roxrud; Dan Joseph Stein; Vegard Skirbekk; John‐Arne Røttingen

doi:10.1186/1478-4505-12-64

Abstract

1 min read

Across therapeutic areas, the Norwegian research investments appeared aligned with the Norwegian disease burden. The correlation between the Norwegian research investments and the global disease burden was much lower.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2013

Opportunities for diabetes research using the Norwegian Cardiovascular Disease Registry

Grace M. Egeland, Vernar Sundvor, Jannicke Igland, Ingvei Seliussen, Yngve Klakegg, Dan Joseph Stein, Rupali Akerkar, Grethe S. Tell, Marta Ebbing

Article2014

Attention to Local Health Burden and the Global Disparity of Health Research

James A. Evans, Jae-Mahn Shim, John P A Ioannidis

Article2013

Association Between Pediatric Clinical Trials and Global Burden of Disease

Florence T. Bourgeois, Karen L. Olson, John P A Ioannidis, Kenneth D. Mandl

Article2022

Global burden of disease study at the world health organization: research methods for the most comprehensive global study of disease and underlying health policies

Lee Smith, Jae Il Shin, Soo Young Hwang, Kalthoum Tizaoui, Elena Dragioti, Louis Jacob, Karel Kostev, Seung Won Lee, Ai Koyanagi

Article2019

The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: Research potential of two nationwide health-care registries

Inger Johanne Bakken, Anja Maria Steinsland Ariansen, Gun Peggy Knudsen, Knut Ivar Johansen, Dan Joseph Stein